- Home
- DRH vs CLDX Comparison
DRH vs CLDX Comparison
Compare DRH & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRH
- CLDX
- Stock Information
- Founded
- DRH 2004
- CLDX N/A
- Country
- DRH United States
- CLDX United States
- Employees
- DRH N/A
- CLDX N/A
- Industry
- DRH Real Estate Investment Trusts
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- DRH Real Estate
- CLDX Health Care
- Exchange
- DRH Nasdaq
- CLDX Nasdaq
- Market Cap
- DRH 1.4B
- CLDX 1.2B
- IPO Year
- DRH 2005
- CLDX 2008
- Fundamental
- Price
- DRH $7.20
- CLDX $19.57
- Analyst Decision
- DRH Hold
- CLDX Buy
- Analyst Count
- DRH 6
- CLDX 8
- Target Price
- DRH $9.17
- CLDX $54.29
- AVG Volume (30 Days)
- DRH 3.0M
- CLDX 840.1K
- Earning Date
- DRH 05-01-2025
- CLDX 05-05-2025
- Dividend Yield
- DRH 5.15%
- CLDX N/A
- EPS Growth
- DRH N/A
- CLDX N/A
- EPS
- DRH 0.18
- CLDX N/A
- Revenue
- DRH $1,129,883,000.00
- CLDX $7,020,000.00
- Revenue This Year
- DRH $1.34
- CLDX N/A
- Revenue Next Year
- DRH $2.45
- CLDX N/A
- P/E Ratio
- DRH $39.89
- CLDX N/A
- Revenue Growth
- DRH 5.12
- CLDX 1.99
- 52 Week Low
- DRH $6.19
- CLDX $14.40
- 52 Week High
- DRH $10.00
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- DRH 47.22
- CLDX 56.38
- Support Level
- DRH $6.82
- CLDX $17.45
- Resistance Level
- DRH $7.40
- CLDX $20.36
- Average True Range (ATR)
- DRH 0.38
- CLDX 1.17
- MACD
- DRH 0.06
- CLDX 0.45
- Stochastic Oscillator
- DRH 83.47
- CLDX 86.74
About DRH Diamondrock Hospitality Company
Diamondrock Hospitality Company is a real estate investment trust that owns lodging properties. Its business is to acquire, own, manage, and renovate full-service hotel properties in the United States. It operates in cities such as Chicago, Boston, New York, Denver, and others. Within DiamondRock's holdings, the majority of the hotel brands include Marriott, Starwood, and Hilton. The revenue is divided between room, food and beverage, and others. The room segment contributes the majority of the revenue. The firm's customers include leisure transients, business transients, and group customers.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.